75 related articles for article (PubMed ID: 5055040)
1. [Utilization of soluble factors produced by lymphocytes as an adjuvant therapeutic method in malignant metastatic tumors. Preliminary results].
May-Levin F; Graffte G; Brulé G
Schweiz Med Wochenschr; 1972 Aug; 102(33):1188-90. PubMed ID: 5055040
[No Abstract] [Full Text] [Related]
2. [Treatment of malignant tumors with spores of Clostridium butyricum M 55. 3. Therapeutic experiments on metastasizing tumors of various organs].
Kretschmer H; Gläser A; Grässer A
Arch Geschwulstforsch; 1972; 39(4):315-21. PubMed ID: 4560621
[No Abstract] [Full Text] [Related]
3. Immunotherapy of patients with cancer.
Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
[No Abstract] [Full Text] [Related]
4. Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors.
Dummer R; Bergh J; Karlsson Y; Horowitz JA; Mulder NH; Huinink DTB ; Burg G; Hofbauer G; Osanto S
Cancer Gene Ther; 2000 Jul; 7(7):1069-76. PubMed ID: 10917210
[TBL] [Abstract][Full Text] [Related]
5. Malignant melanoma.
Moore GE; Gerner RE
Surg Gynecol Obstet; 1971 Mar; 132(3):427-36. PubMed ID: 5546295
[No Abstract] [Full Text] [Related]
6. [Effects of soluble factors released by the lymphocyte on tumorigenesis in man].
May-Levin F; Graffte G; Brule G
C R Acad Hebd Seances Acad Sci D; 1971 Jun; 272(23):2996-9. PubMed ID: 4997321
[No Abstract] [Full Text] [Related]
7. In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma.
Steele G; Wang BS; Richie J; Wilson RE; Ervin T; Yankee R; Fallon M; Mannick JA
Cancer Res; 1980 Jul; 40(7):2377-82. PubMed ID: 6155992
[No Abstract] [Full Text] [Related]
8. Intralesional injection of interleukin-2-expanded autologous lymphocytes in melanoma and breast cancer patients: a pilot study.
Adler A; Stein JA; Kedar E; Naor D; Weiss DW
J Biol Response Mod; 1984 Oct; 3(5):491-500. PubMed ID: 6334137
[TBL] [Abstract][Full Text] [Related]
9. Influence of interferon on C19-steroids in urine of malignant skin melanoma and malignant breast neoplasm patients.
Marković L; Ivanović S; Konstantinović I; Ikić D; Micić J; Stakić B
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):416-8. PubMed ID: 6238002
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic and prognostic programming in cases of malignant melanoma].
Veronesi U
Schweiz Med Wochenschr; 1970 Jun; 100(23):976-81. PubMed ID: 5524713
[No Abstract] [Full Text] [Related]
11. [Regression of melanoma metastases after injection of Freund's adjuvant].
Herrmann WP; Tritsch H; Gartmann H
Hautarzt; 1970 Apr; 21(4):181-3. PubMed ID: 5524564
[No Abstract] [Full Text] [Related]
12. [Results of adjuvant therapy with the preparation Poly-a Poly-u in patients with malignant melanoma during a 10-year observation].
Pawlicki M; Jońca M; Krzemieniecki K; Zuchowska-Vogelgesang B
Wiad Lek; 1993 Dec; 46(23-24):912-4. PubMed ID: 7900387
[TBL] [Abstract][Full Text] [Related]
13. Thermoradiotherapy of refractory malignant tumors: an experience with microwave and RF capacitive hyperthermia.
U R; Hiraoka M; Takahashi M; Abe M; Matsuda T; Sugiyama A; Nakada Y; Yamamoto I; Sugahara T
Med Instrum; 1984; 18(3):181-6. PubMed ID: 6748997
[TBL] [Abstract][Full Text] [Related]
14. [Adjuvant and palliative therapy of melanoma. Current status].
Tilgen W
Chirurg; 1994 Mar; 65(3):153-63. PubMed ID: 7514966
[TBL] [Abstract][Full Text] [Related]
15. [Immunological mechanisms of metastasis].
Flad HD
Aktuelle Probl Chir Orthop; 1980; 74():20-5. PubMed ID: 6104925
[No Abstract] [Full Text] [Related]
16. Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance.
Koon HB; Atkins MB
Expert Rev Anticancer Ther; 2007 Jan; 7(1):79-88. PubMed ID: 17187522
[TBL] [Abstract][Full Text] [Related]
17. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
[TBL] [Abstract][Full Text] [Related]
18. Clinical experiences in immunotherapy of cancer.
Krementz ET; Samuels MS; Wallace JH; Benes EN
Surg Gynecol Obstet; 1971 Aug; 133(2):209-17. PubMed ID: 5284416
[No Abstract] [Full Text] [Related]
19. Microwave-induced hyperthermia in cancer treatment: apparatus and preliminary results.
Mendecki J; Friedenthal E; Botstein C; Sterzer F; Paglione R; Nowogrodzki M; Beck E
Int J Radiat Oncol Biol Phys; 1978; 4(11-12):1095-103. PubMed ID: 721651
[No Abstract] [Full Text] [Related]
20. [Malignant melanoma of the skin].
Stein G
Z Haut Geschlechtskr; 1971 Jul; 46(13):409-14. PubMed ID: 5110514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
